P3.08 C-REACTIVE PROTEIN BUT NOT ADVANCED GLYCATION END-PRODUCTS ARE RELATED TO ALTERED GLUCOSE METABOLISM AND ARTERIAL STIFFENING IN THE MIDDLE AGED METABOLIC SYNDROME SUBJECTS: D...

by L. Ryliskyte, A. Laucevicius, J. Badariene, R. Navickas, S. Solovjova
Published 2013-11-01

P10.14 AORTIC PULSE WAVE VELOCITY IS AN INDEPENDENT CARDIOVASCULAR EVENT PREDICTOR IN HIGH CARDIOMETABOLIC RISK GROUP

by R. Navickas, L. Ryliskyte, R. Puronaite, S. Solovjova, J. Badariene, A. Laucevicius
Published 2014-11-01

P1.30 IN HIGH CVD RISK GROUP ARTERIAL FUNCTION MARKERS CORRELATE WEAKLY WITH PWV AND AIXHR75 AS EXCEPTIONS

by R. Navickas, L. Ryliskyte, A. Jakaitiene, Z. Visockiene, J. Badariene, A. Laucevicius
Published 2012-11-01

P10.12 AORTIC STIFFNESS IS AN INDEPENDENT DETERMINANT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN METABOLIC SYNDROME PATIENTS

by L. Ryliskyte, J. Celutkiene, S. Solovjova, R. Puronaite, J. Badariene, R. Navickas, A. Laucevicius
Published 2014-11-01

P1.33 PREDICTORS OF ARTERIAL MARKERS IN METABOLIC SYNDROME PATIENTS: ARTERIAL HYPERTENSION AND GENDER OUTBID DYSLIPIDEMIA

by L. Ryliskyte, Z. Visockiene, K. Ryliskiene, R. Navickas, J. Badariene, A. Jakaitiene, A. Laucevicius
Published 2012-11-01

P11.26 CARDIOVASCULAR RISK IN THE VIEW OF INDIVIDUAL RISK FACTORS IN PATIENTS WITH MORE THAN 1 RISK FACTOR PRESENT

by R. Navickas, L. Rimsevicius, L. Ryliskyte, Z. Visockienė, M. Ozary-Flato, A. Laucevicius, M. Kovaite, J. Badariene
Published 2011-11-01